Development of autoimmune diabetes with severe diabetic ketoacidosis and immune-related thyroiditis secondary to durvalumab: a case report

Immune-mediated endocrinopathies are among the most frequent immune-related adverse events (irAEs) with immune checkpoint inhibitors (ICIs) targeting programmed death-ligand 1 (PD-L1)/PD-1. However, the development of auto-immune diabetes is an uncommon event during PD(L)-1 blockade, either as monot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Ana Rita, Russo, Alessandro, Li, Andrew Y., McCusker, Michael G., Kroopnick, Jeffrey Myles, Scilla, Katherine, Mehra, Ranee, Rolfo, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653143/
https://www.ncbi.nlm.nih.gov/pubmed/33209634
http://dx.doi.org/10.21037/tlcr-20-408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653143/
https://www.ncbi.nlm.nih.gov/pubmed/33209634
http://dx.doi.org/10.21037/tlcr-20-408

Ejemplares similares